The authors noticed a duplication of data in Fig. 3 B between the panels representing subcellular fractionations of wild-type and vps21∆ cells. Given the time that has elapsed since the original date of publication, the original data could not be found to correct the figure, so a new version of Fig. 3 B from a recent repeat of the experiment has been provided below.
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The html and pdf versions of this article have been corrected. The error remains only in the print version. (A) Tlg1p-containing complexes were immunoprecipitated from cells harboring the glc7-10 mutation (NOzY23) grown at 25°C (25°C), or grown at 25°C and then incubated at 37°C for 10 min before cell lysate preparation (37°C). Immunoblot analysis was used to detect the amount of Tlg1p, Tlg2p, Vti1p, HA-tagged Snc2p, and Vps45p in the immunoprecipitated complexes. (B) wild-type (SF838-9D), sec18-1 (NOzY22), vps21D (SGY79), and glc7-10 (PAY704-1) cells were incubated at 37°C for 10 min before fractionation by differential centrifugation to yield a whole cell extract (WCE), a low-speed membrane pellet (P13), a high-speed membrane pellet (P100), and a soluble, cytosolic fraction (S100). The amount of Vps45p in each fraction was assessed using immunoblot analysis.
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